Cosmos Health (COSM) said Monday it entered into a distribution agreement with Virax Biolabs (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.
Financial details weren't disclosed.
Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.
Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.
The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.
Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.
Price: 0.58, Change: -0.04, Percent Change: -6.15
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.